Nalaganje...
Fulminant type 1 diabetes mellitus with anti‐programmed cell death‐1 therapy
Anti‐programmed cell death‐1 (PD‐1) antibodies are regarded as a risk factor for insulin‐dependent diabetes mellitus as a side‐effect. While a small number of cases have been reported, evidence remains limited. This is the first report of an Asian patient developing insulin‐dependent diabetes during...
Shranjeno v:
| izdano v: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089956/ https://ncbi.nlm.nih.gov/pubmed/27181090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12531 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|